Medicina
Facultad
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (95)
2024
-
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study
Journal of Thoracic Oncology, Vol. 19, Núm. 2, pp. 285-296
-
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272
-
International Delphi Study on Wound Closure and Dressing Management in Joint Arthroplasty: Part 1: Total Knee Arthroplasty
Journal of Arthroplasty, Vol. 39, Núm. 4, pp. 878-883
-
International Delphi Study on Wound Closure and Incision Management in Joint Arthroplasty Part 2: Total Hip Arthroplasty
Journal of Arthroplasty
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial
Journal of Thoracic Oncology, Vol. 18, Núm. 12, pp. 1731-1742
-
Cerebral Oximetry Monitoring in Extremely Preterm Infants
New England Journal of Medicine, Vol. 388, Núm. 16, pp. 1501-1511
-
Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (Intensive Care Medicine, (2023), 49, 6, (615-632), 10.1007/s00134-023-07033-8)
Intensive Care Medicine
-
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
European Respiratory Journal, Vol. 61, Núm. 4
-
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Intensive Care Medicine, Vol. 49, Núm. 6, pp. 615-632
-
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: A pooled analysis from the Phase 3 clinical trial programme
Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 11, pp. 2672-2682
-
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer
Breast, Vol. 67, pp. 94-101
-
Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research
Alzheimer's and Dementia, Vol. 19, Núm. 12, pp. 5817-5836
-
Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure
Acta Neuropathologica, Vol. 145, Núm. 1, pp. 127-143
-
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome
Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1081-1095
-
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
Annals of Oncology, Vol. 34, Núm. 10, pp. 885-898
-
Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
The Lancet Infectious Diseases, Vol. 23, Núm. 7, pp. e259-e265
-
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study
Clinical Infectious Diseases, Vol. 76, Núm. 3, pp. E995-E1003
-
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2893-2903
-
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study
Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427